Urinary matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 biomarkers for predicting renal scar in children with urinary tract infection
- 1 January 2017
- journal article
- research article
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 43 (4) , 536-542
Abstract
Objective: Urinary tract infection occurs in 1.8–6.6% of children under 6 years old. The aim of this study was to assess the urinary concentrations of matrix metalloproteinase 9 (MMP9) and tissue inhibitor of metalloproteinase 1 (TIMP1), in children with acute pyelonephritis (APN) and the potential to develop renal scarring. Material and methods: Children who had experienced an episode of APN were divided into 2 groups. Group 1 included children with APN who exhibited scarring and group 2 included children with APN who had a normal 99mTechnetium dimercaptosuccinic acid scan. Urinary levels of MMP9 and TIMP1 were measured in the acute phase of infection. A receiver operating characteristic curve was generated to allow calculation of cut-off values. Results: Sixty-one children were enrolled across the 2 groups: group 1 contained 16 patients (all female); group 2, 38 children (36 female and 2 male). Urinary levels of MMP9 and TIMP1 were significantly higher in group 1 than in group 2 (p=0.037 and 0.022 respectively). For comparison of groups 1 and 2, the cut-off values were measured as 75.5 ng/mL (sensitivity 62.5%, specificity 71.1%, positive predictive value, PPV, 48%, negative predictive value, NPV, 82%), 16.1 ng/mL (sensitivity 75%, specificity 55.3%, PPV 41%, NPV 84%), and 1310.7 ng/mL (sensitivity 75% specificity 60.5%, PPV 44%, NPV 85%) for MMP9, TIMP1, and MMP9×TIMP1 levels, respectively. Conclusion: Evaluation of urinary MMP9 and TIMP1 levels may help to identify children with APN who are at risk of developing renal scarring. Cite this article as: Abedi SM, Mohammadjafari H, Rafiei A, Bazi S, Yazdani P. Urinary matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 biomarkers for predicting renal scar in children with urinary tract infection. Turk J Urol 2017; 43(4): 536-42.Keywords
This publication has 27 references indexed in Scilit:
- Predictive Accuracy of Urinary neutrophil gelatinase associated lipocalin (NGAL) for renal parenchymal involvement in Children with Acute PyelonephritisElectronic Physiciane, 2016
- Matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in vesicoureteral refluxPediatric Nephrology, 2011
- Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in ChildrenJournal of Urology, 2010
- [Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis].2009
- Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectivesKidney International, 2008
- Serum and urine cystatin C levels in children with post-pyelonephritic renal scarring: a pilot studyInternational Urology and Nephrology, 2007
- Role of matrix metalloproteinases in renal pathophysiologiesAmerican Journal of Physiology-Renal Physiology, 2007
- Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Acute Pyelonephritis and Renal ScarringPediatric Research, 2003
- Imaging Studies after a First Febrile Urinary Tract Infection in Young ChildrenNew England Journal of Medicine, 2003
- Expression of the Type IV Collagenase System during Mouse Kidney Development and Tubule SegmentationJournal of the American Society of Nephrology, 2001